Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines

Introduction: Pyridopyrimidines belong to a class of compounds characterized by the presence of nitrogen as heteroatoms. These compounds exhibit diverse biological effects, particularly showing promise as anticancer agents, including actions that inhibit CDK4/6. Methods: We designed and synthesized...

Full description

Saved in:
Bibliographic Details
Main Authors: Chaithra R Shetty, C. S. Shastry, Parasuraman P, Srinivas Hebbar
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2024-07-01
Series:BioImpacts
Subjects:
Online Access:https://bi.tbzmed.ac.ir/PDF/bi-14-29951.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!